IMR Press / JIN / Volume 23 / Issue 4 / DOI: 10.31083/j.jin2304083
Open Access Original Research
Neither Amphetamine nor Sub-Anesthetic Ketamine Treatment during Adolescence Impairs Devaluation in Rats Tested during Adulthood
Show Less
1 Department of Psychological Sciences, Kansas State University, Manhattan, KS 66506, USA
*Correspondence: pickens@ksu.edu (Charles L. Pickens)
J. Integr. Neurosci. 2024, 23(4), 83; https://doi.org/10.31083/j.jin2304083
Submitted: 17 January 2024 | Revised: 21 February 2024 | Accepted: 27 February 2024 | Published: 18 April 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Much of the existing animal literature on the devaluation task suggests that prior repeated exposure to drugs of abuse during adulthood can impair goal-directed action, but the literature on human drug users is mixed. Also, the initiation of drug use often occurs during adolescence, but examinations of the effects of drug exposure during adolescence on behavior in the devaluation task are lacking. Methods: We examined whether repeated exposure during adolescence to amphetamine (3 mg/kg injections every-other day from post-natal day 27–45) or ketamine (twice daily 30 mg/kg injections from post-natal day 35–44) would impair behavior in a devaluation test when tested drug-free in adulthood. Rats were trained to press a left lever with a steady cue-light above it for one reinforcer and a right lever with a flashing cue-light above it for a different reinforcer. We tested whether any impairments in goal-directed action could be overcome by compensation between strategies by giving rats information based on lever-location and cue-lights during the test that was either congruent (allowing compensation) or incongruent (preventing compensation between strategies) with the configurations during training. Results: Our results provided no evidence for impairment of goal-directed action during adulthood after adolescent amphetamine or ketamine exposure. Conclusions: We discuss possible reasons for this discrepancy with the prior literature, including (1) the age of exposure and (2) the pattern in the previous literature that most previous demonstrations of drug exposure impairing devaluation in laboratory animals may be attributed to either drug-associated cues present in the testing environment and/or accelerated habit learning in tasks that predispose laboratory animals towards habit formation with extended training (with training procedures that should resist the formation of habits in the current experiment). However, additional research is needed to examine the effects of these factors, as well a potential role for the particular doses and washout periods to determine the cause of our finding of no devaluation impairment after drug exposure.

Keywords
amphetamine
ketamine
devaluation
decision-making
addiction
schizophrenia
1. Introduction

Goals can change over time, and it is important to adapt our behavior as our goals change (goal-directed behavior). We also need to integrate information from several past experiences to guide our behavior. One task often used to model goal-directed behavior is the devaluation task [1, 2]. In operant devaluation tasks, specific responses earn specific rewards/reinforcers. The outcome (e.g., food) value is then decreased. In a third stage, the devaluation effect is measured (in extinction) by determining if there is a reduction in responses that previously earned the outcome.

Previous research has found that the ability to decrease responses to devalued rewards is impaired in multiple psychiatric disorders [3, 4, 5, 6, 7] (but see [8]), but the evidence for impaired goal-directed behavior in human drug users is mixed [9, 10, 11, 12, 13]. This mixed evidence in the literature is observed even though addictive drug use is associated with abnormalities in many human brain areas associated with flexible behavior that is goal-directed, including orbitofrontal cortex (OFC), amygdala, dorsal and ventral striatum, and prefrontal cortex areas analogous to the rodent prelimbic cortex (PL) [14, 15, 16, 17, 18, 19]. The literature on goal-directed behavior impairments in human drug users may be mixed due to compensatory mechanisms [20, 21, 22, 23, 24], in which functions subserved by impaired brain regions are assumed by other brain regions. If the neural substrates of the strategy that usually guide goal-directed behavior were dysfunctional, apparently normal behavior could be maintained through behavioral compensation. Behavioral compensation occurs when function is maintained after a neurobiological disruption through use of an alternative strategy. However, there is minimal research on potential compensatory changes in the devaluation task because devaluation researchers design experiments to isolate the particular associations guiding goal-directed behavior. Specifically, devaluation tasks often provide information about which responses will earn specific outcomes either through information about a fixed spatial location of the response or through discrete stimuli that can be presented for short periods of time (such as lights, tones or objects/pictures on a touchscreen), but rarely with both types of information within the same task. There are several sets of terminology that could be used for this distinction, and it is possible to think of the spatial location as a “location cue” in which case both sources of information represent different types of cues, but we will largely refer to use of the different types of information as different “strategies”. Separation of tasks into those that can only be guided by responses to a location [25, 26, 27, 28, 29] or can only be guided by discrete stimuli [30, 31, 32, 33, 34, 35, 36, 37, 38, 39] prevents study of how a new strategy might be used when the neural substrates of the usual strategy are compromised.

Our lab has recently begun to examine the possibility of compensation between strategies using a new version of the devaluation task. In our devaluation task, lever-light compounds earn separate reinforcers (e.g., left lever + steady cue-light earns precision pellets and right lever + flashing cue-light earns chocolate pellets) (Fig. 1A). Our previous research showed that pretraining inactivation of basolateral amygdala (BLA) or mediodorsal thalamus (MD), but not lateral orbitofrontal cortex (lOFC) or PL impaired goal-directed behavior in our task if the lever-light-food compounds are the same in testing as in training (a Cue Normal Test- in which lever-location and cue-lights give congruent information about outcomes) (Fig. 1B) [40]. Our finding that inactivation of lOFC or PL did not impair devaluation was unexpected, as the prior literature suggests that either lOFC or PL should be necessary for goal-directed behavior. If responses to a fixed location earn an outcome, goal-directed behavior is disrupted by pretraining PL inactivation/lesions [25, 26, 27, 28, 29]. In tasks where discrete cues (like lights or presentation of two response options during trials separated by an intertrial interval) indicate the expected outcome and/or time to respond, goal-directed behavior tends to be disrupted by lOFC inactivation/lesions [30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 41, 42, 43]. However, our inactivation results could be explained if the lever-location and discrete cues above the levers provide redundant outcome information, allowing the rats to use alternative strategies when the neural substrates supporting one strategy are nonfunctional. In support of this hypothesis, our preliminary research (available in preprint form) showed that devaluation behavior is impaired by pretraining combined lesions of both PL and lOFC (which would prevent compensation between the two strategies putatively supported by the two brain areas) but not lesions of either PL or lOFC alone [44]. Likewise, rats with pretraining PL lesions are impaired in devaluation in a test in which the lever-location and cue-lights are mismatched between training and testing (a Cue Switched Test- in which lever-location and cue-lights give incongruent information about outcomes and compensation between strategies cannot maintain similar behaviors- see Fig. 1C) (unpublished data).

Fig. 1.

Training and testing procedures. (A) Cued-trial operant training. (B) Cue Normal test lever-light compounds. (C) Cue Switched test lever-light compounds.

In addition, most animal research on long-term effects of exposure to addictive drugs on behavior in the devaluation task examined effects of exposure during adulthood, but human drug use often begins during adolescence and the age of exposure is associated with differential outcomes. A substantial portion of the American population uses alcohol or illicit drugs during the teenage years [45]. For example, according to one recurring yearly survey, 50–70%, 30–40%, and 10–20% of American 12th graders reported having used alcohol, marijuana/hashish, and illicit drugs other than marijuana/hashish, respectively, within the last year in each year from 2005–2020 [46]. Studies have found evidence that the majority of people admitted for treatment of substance use began this use prior to age 18 [47], that there is a linear decrease in the risk of developing a substance use problem within 7 years as the age of first use increases from 13–14 to 17 [48], and that initiation of use of alcohol or marijuana prior to age 14 leads to a greater than 4× increase in the rate of diagnosed substance use problems for that substance compared with people who initiated use after age 18 [49]. Previous research from rodent models also suggests that there may be more significant long-term behavioral and neurobiological effects of drug exposure if this exposure occurs during adolescence, rather than adulthood (as reviewed in [50]).

Here, we tested whether adolescent exposure to the psychostimulant amphetamine or adolescent exposure to the dissociative anesthetic drug ketamine would lead to impairment in goal-directed behavior in our task. We also tested whether any such deficits might be hidden by compensation in a version in which both strategies lead to the same behavioral pattern during testing. Prior research has demonstrated behavioral impairments weeks after repeated exposure to psychostimulants (including methamphetamine, amphetamine, and cocaine) in devaluation tasks requiring cue-based or lever-location strategies [51, 52, 53, 54, 55, 56] (but see [57, 58, 59] for alternative explanations of these findings- detailed in the Discussion section). For Experiment 1, we based our amphetamine dosing regimen on a previous experiment which suggested that 3 mg/kg injections of amphetamine every-other day from post-natal day (PND) 27–45 led to decreased bursting in PL in response to saline injections during adulthood [60]. For Experiment 2, our dosing regimen was a modified version of the one used in previous experiments using repeated subanesthetic injections of 30 mg/kg ketamine. This dosing regimen has been shown to lead to behavioral impairments consistent with dysfunction of PL and/or lOFC (see [61] for results consistent with lOFC dysfunction based on previous research [62, 63, 64] and see [65] for results consistent with PL dysfunction based in previous research [63, 66]). However, we combined the twice daily injections from [61] with the 10 days of injections from [65]. Although the particular regimen differed between ketamine (twice daily injections daily for 10 days) and amphetamine (an injection every other day), both regimens finished on PND 44–45. To the best of our knowledge, this is one of the first (and possibly the first) examination of the long-term effects of adolescent psychostimulant or dissociative anesthetic exposure in the devaluation task. As described below, we found no evidence for impaired goal-directed behavior in either test type after either manipulation. We then discuss several factors that may determine whether exposure to drugs of abuse leads to long-term devaluation impairments.

2. Materials and Methods
2.1 Subjects

Long Evans rats were bred in our facility. For the Experiment 1 data, there were 50 rats (21 male, 29 female). For the Experiment 2 data, there were 103 rats (48 male, 55 female). Rats were weaned on PND 21. Following weaning, animals were individually housed and maintained on a 12-hour reverse light-dark cycle with lights off at 07:00 am in a temperature and humidity-controlled room. Water was available ad libitum throughout the experiment and food was available ad libitum until the beginning of the food restriction period. At PND66, the rats were food-restricted to 85% of their initial free-feeding weight by daily feedings with a minimum of 5 g of food chow per day. Once rats reached their 85% target weights, the target body weight increased by 1 g/day for males or 0.25 g/day for females for the remainder of the experiment, such that the rats’ target weights gradually increased by 7 g/week or 1.75 g/week. The different feeding regimens in male and female rats are meant to cause similar leverpress rates in the two sexes (determined from our lab’s pilot data), and is consistent with our published research using the devaluation task [40].

2.2 Animal Ethics Statement

All procedures and animal care were approved by and conducted in accordance with the Kansas State University Institutional Animal Care and Use Committee guidelines (approvals #4345 and 4422) and were conducted in accordance with the U.S. National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. All rats were euthanized with a lethal dose of Fatal-Plus (pentobarbital solution; #2831, 2846, and 2868; Vortech Pharmaceuticals, Dearborn, MI, USA) followed by decapitation as a secondary method of confirming death after the completion of the experiments, consistent with the recommendations of the Panel on Euthanasia of the American Veterinary Medical Association.

2.3 Apparatus

The behavioral training occurred in 12 operant chambers (Med Associates, St Albans, VT, USA). Each chamber had a pellet dispenser that was used to deliver 45-mg precision pellets (catalog #1811155; TestDiet, Richmond, IN, USA), 45-mg chocolate-flavored sucrose pellets (catalog #1811256; TestDiet, Richmond, IN, USA), or 45-mg grain pellets (catalog #1812127; TestDiet, Richmond, IN, USA). The particular pellet that was delivered depended upon the phase of the experiment. Each chamber was equipped with two retractable levers on either side of the food-cup at approximately one-third of the chamber’s total height. A white cue-light was located above each of the levers. A red house-light was located on the back wall in the top–center. The equipment was controlled by (and all responses were recorded by) a Dell OptiPlex computer (Dell Inc., Round Rock, TX, USA) with Med-PC for Windows (Med Associates, St Albans, VT, USA).

2.4 General Behavioral Training and Testing

Behavioral training occurred after rats had acclimated to the restricted feeding conditions. This training occurred during the dark phase of the light:dark cycle. Rats were weighed and received their daily feeding after each day’s training session.

This experiment utilized the same training and testing procedures used and described in detail by Fisher, Pajser, and Pickens [40]. In brief, the rats were trained with three magazine training sessions (one with each of the three types of food pellets- chocolate, grain, and precision). The magazine training sessions occurred once-daily for 40 min. During each session, one of the pellets was delivered every 125 seconds. The rats were then trained to leverpress in two fixed-interval-1 training sessions during each day for two days (with afternoon sessions occurring 2–4 hours after the morning sessions). In these sessions, rats could earn up to 50 grain pellets and leverpresses could earn a pellet each second under the fixed-interval-1 schedule. Each lever was trained in a separate session for a maximum of 50 pellets or 60 minutes per session, with training for each lever in the morning on one day and in the afternoon on the other day.

After this pretraining was complete, the rats were trained in 4 cued-trial operant sessions, given once daily. The rats were trained with two sessions for each of the two lever-cue-reinforcer relationship. During the first and the fourth training session, responses to the left lever (with illumination of a steady white cue-light above the lever) resulted in precision pellets. During the second and the third training session, responses to the right lever (with flashing [2 Hz] illumination of white cue-light above it) resulted in chocolate pellets. Each cued-trial training session lasted for 40 min and contained 40 trials. During each 40-sec trial, leverpresses could earn two pellets, with one pellet available at a variable time during the first 20 sec and pellet available at a variable time during the last 20 sec (a modified VI20 reinforcement schedule during the trials). Rats could earn a maximum of 80 pellets during each session. During the inter-trial intervals (13–19 sec with a mean of 20 sec), the levers were retracted without any illumination of the cue-lights.

Following cued trial training, a choice test was administered. In the operant chambers, rats received a 1-h satiation session with access to 30 g of either chocolate or precision pellets (identity counterbalanced) presented in ceramic bowls. Fifteen minutes after the satiation period, rats received a 12-min choice test with twelve 40-sec trials. During each trial, both levers with cue-lights were presented and responding was measured. In the Cue Normal condition, the cue-lights above the levers were in the same position as during training (e.g., steady cue-light above the left lever). Responding should be decreased for the cue-light+lever compound that earns the devalued reinforcer if rats devalue properly. For the Cue Switched condition, the cue-lights above the levers were in the opposite position as during training, such that the flashing light was above the left lever and the steady light was above the right lever. Our previous research suggests that neurobiologically intact rats decrease responses made to the lever in the fixed location that previously earned the devalued/sated food rather than the lever below the cue-light associated with the sated food under these conditions [40]. However, our preliminary research suggests that PL lesions lead to impaired devaluation with a trend towards lower responding to the lever below the cue-light associated with the sated food, even though this lever-location is associated with the non-sated food (unpublished data). Lever presses did not earn pellets during the test to ensure the rats used their memory representations of the cue-lever combinations to guide behavior. Next, rats received two cued-trial retraining sessions, one with each lever+cue-light-food compound (with the original configurations used during training), to return lever pressing rates to baseline. Rats then completed another choice test with the opposite pellet devalued during the satiation period and with the same cue-light-+lever combinations as in the first test (so Cue Switched groups once again had mismatched cue-light+lever compounds between training and test). Testing with both pellets sated controls for any differences in preference for them, as we often observe higher lever-responding for the precision pellets and higher consumption of them during the satiation period (see [67] for an example). Any preference should be averaged out by testing with both pellets sated. No rats were excluded for low responding in the choice tests. However, in Experiment 1, one rat was excluded because of a jammed feeder that led to extinction of the lever-press response and one rat was excluded as an experimental error led to them not being tested in a second choice test.

2.5 Specific Experiments
2.5.1 Experiment 1- Effects of Repeated Amphetamine Injections during Adolescence

Fifty-one rats received 10 intraperitoneal (i.p) injections of either amphetamine (3 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) or an equivalent volume of sterile saline (1 mL/kg) every other day from PND 27–45. After the final injection, rats were kept in their home cages with ad libitum access to food and water until food restriction began at PND 66. The rats then received training and testing as described above. The number of rats in each drug- and testing-condition was: Amphetamine-Cue Normal = 6 males and 8 females, Amphetamine-Cue Switched = 5 males and 7 females, Saline- Cue Normal = 5 males and 8 females, Saline-Cue Switched = 5 males and 6 females.

2.5.2 Experiment 2- Effects of Repeated Ketamine Injections during Adolescence

One-hundred and three rats received twice daily i.p. injections of either 30 mg/kg ketamine (Batch #402408, Zoetis, Parsippany–Troy Hills, NJ, USA and Batch #AH0358U, VetOne, Boise, ID, USA) or 2 mL/kg sterile saline solution from PND 35–44 (20 injections total). After the final injection, rats were kept in their home cages with ad libitum access to food and water until food restriction began at PND 66. The rats then received training and testing as described above. The number of rats in each drug- and testing-condition was: Ketamine-Cue Normal = 12 males and 12 females, Ketamine-Cue Switched = 12 males and 15 females, Saline-Cue Normal = 12 males and 11 females, Saline-Cue Switched = 12 males and 17 females.

3. Results
3.1 Experiment 1
3.1.1 Cued-Trial Lever Training Results

We analyzed the number of leverpresses/session in the training phase (Fig. 2A) with a mixed-factor analysis of variance (ANOVA) with the between-subjects factors of Treatment (Amphetamine and Saline), Sex (Male and Female), and Test Type (Cue Normal and Cue Switched; this represented the future test condition after training) and the within-subjects factors of Pellet/Lever (Precision/Left vs. Chocolate/Right) and Training Day. This analysis found significant effects of Pellet/Lever F(1, 42) = 34.4, p < 0.0001 and Training Day F(2, 84) = 45.3, p < 0.0001 and a significant interaction of Pellet/Lever X Training Day F(2, 84) = 14.9, p < 0.0001. No other main effects or interactions were significant (all p > 0.05). A post-hoc analysis of the Pellet/Lever X Training Day interaction revealed that rats made more presses/session for the left lever that earned precision pellets than for the right lever that earned chocolate pellets on the second training day and during the retraining session between the tests (both p < 0.01), but not in the first training day for each pellet (p > 0.10).

Fig. 2.

Experiment 1 data. (A) Leverpresses/session (mean + SEM) during training. Left = female groups. Right = male groups. Circles = pressing on left lever for precision pellets. Squares = pressing on right lever for chocolate pellets. Black symbols = amphetamine groups. White symbols = saline groups. On x-axis, 1 and 2 represent first 2 pre-test training sessions for each pellet. R represents the retraining session for each pellet between the two tests. (B) Lever presses/trial (mean ± SEM) in each group during the devaluation test in Experiment 1 (averaged test). (C) White bars represent responding on the nondevalued lever. Black bars represent responding on the devalued lever. SEM, standard error of the mean; F, female; M, male; Normal, behavior in the Cue Normal test; Switch, behavior in the Cue Switched test.

3.1.2 Choice Test Results

We analyzed the test results (Fig. 2B,C) using a mixed-factor ANOVA with the between-subjects factors of Treatment (Amphetamine and Saline), Sex (Male and Female), and Test Type (Cue Normal and Cue Switched) and the within-subjects factor of Lever (Devalued and Nondevalued). This analysis found a significant effect of Lever F(1, 42) = 25.9, p < 0.0001. No other main effects or interactions were significant (all p > 0.22). These results indicate that all groups showed sensitivity to outcome devaluation regardless of whether they had a history of drug or saline exposure.

3.2 Experiment 2
3.2.1 Cued-Trial Lever Training Results

We analyzed the number of leverpresses/session during training (Fig. 3A) using a mixed-factor ANOVA with the between-subjects factors of Treatment (Ketamine and Saline) and Sex (Male and Female) and the within-subjects factors of Pellet/Lever (Precision/Left and Chocolate/Right) and Training Day. This analysis found significant effects of Sex F(1, 99) = 6.6, p = 0.01, Pellet/Lever F(1, 99) = 8.4, p = 0.005 and Training Day F(2, 198) = 98.7, p < 0.0001 and a significant interaction of Pellet/Lever X Training Day F(2, 198) = 43.0, p < 0.0001. No other main effects or interactions were significant (all p > 0.15). A post-hoc analysis of the Pellet/Lever X Training Day interaction revealed that rats made more presses/session for the left lever that earned precision pellets than for the right lever that earned chocolate pellets on the second training day (p < 0.01), but not in the first training day for each pellet or the retraining session between the tests (all p > 0.10).

Fig. 3.

Experiment 2 data. (A) Leverpresses/session (mean + SEM) during training. Left = female groups. Right = male groups. Circles = pressing on left lever for precision pellets. Squares = pressing on right lever for chocolate pellets. Black symbols = ketamine groups. White symbols = saline groups. On x-axis, 1 and 2 represent first 2 pre-test training sessions for each pellet. R represents the retraining session for each pellet between the two tests. (B) Lever presses/trial (mean ± SEM) in each group during the devaluation test in Experiment 2 (averaged test). (C) White bars represent responding on the nondevalued lever. Black bars represent responding on the devalued lever. F, female; M, male; Normal, behavior in the Cue Normal test; Switch, behavior in the Cue Switched test.

3.2.2 Choice Test Results

We analyzed the test results (Fig. 3B,C) using a mixed-factor ANOVA with the between-subjects factors of Treatment (Ketamine and Saline), Sex (Male and Female), and Test Type (Cue Normal and Cue Switched) and the within-subjects factor of Lever (Devalued and Nondevalued). This analysis found significant effects of Test Type F(1, 95) = 4.8, p = 0.03 and Lever F(1, 95) = 5.7, p = 0.02. No other main effects or interactions were significant (all p > 0.05). These results indicate that all groups showed sensitivity to outcome devaluation regardless of whether they had a history of drug or saline exposure, although the overall devaluation effect was fairly weak even in the Saline rats. Visual inspection of the devaluation effect in Experiment 2 suggested that the devaluation effect may have been smaller in the Cue Switched condition, but this was not supported by a Lever X Test Type interaction.

3.3 Preference Ratios

We have traditionally assessed devaluation effects in our previous research by assessing the number of leverpresses, but an alternative measure of the devaluation effect can be calculated by assessing the ratio of responding on the lever that previously earned the nondevalued food to responding on the lever that previously earned the devalued food. We calculated this using the formula (with the “nondevalued” and “devalued” lever designated based on the levers’ fixed spatial location):

Preference ratio = ( Responses on the nondevalued lever – Responses on the devalued lever ) ( Responses on the nondevalued lever + responses on the devalued lever )

This measure normalizes the change in responding based on the overall level of responding. For example, using this measure, a low responding rat that presses 4 times on the nondevalued lever and 2 times on the devalued lever would have a preference ratio equivalent to another rat that presses 30 times on the nondevalued lever and 15 times on the nondevalued lever. In this case, exclusive responding on the nondevalued lever results in a preference ratio of 1.0, exclusive responding on the devalued lever results in a preference ratio of –1.0, and equal responding on the 2 levers results in a preference ratio of 0.0.

3.3.1 Preference Ratios in Experiment 1

We analyzed the test results of Experiment 1 (Fig. 4A,B) using a mixed-factor ANOVA with the between-subjects factors of Treatment (Amphetamine and Saline), Sex (Male and Female), and Test Type (Cue Normal and Cue Switched). This analysis found a no significant main effects or interactions (all p > 0.32). We then examined whether the overall pattern using this measure supported a conclusion that goal-directed action was being expressed using a single-sample t-test. As there were no differences between groups, we compared the preference ratio across the entire sample to 0 (the score that would indicated that there was no preference). We found that the preference score for the sample was significantly different from 0: t(46) = 5.3, p < 0.001. These results indicate that there was a significant devaluation effect (based on the lever-location) in Experiment 1 when the scores were normalized for the overall level of responding and that there was no evidence that the magnitude of this devaluation effect using this measure differed across the different groups.

Fig. 4.

Preference ratio data (mean + SEM) in each group during the devaluation test from Experiments 1 and 2. (A) Preference ratio in Experiment 1 averaging across sex. (B) Preference ratio in Experiment 1 separated by sex. (C) Preference ratio in Experiment 2 averaging across sex. (D) Preference ratio in Experiment 2 separated by sex. Pref, preference; F, female; M, male; Normal, behavior in the Cue Normal test; Switch, behavior in the Cue Switched test.

3.3.2 Preference Ratios in Experiment 2

We analyzed the test results of Experiment 2 (Fig. 4C,D) using a mixed-factor ANOVA with the between-subjects factors of Treatment (Ketamine and Saline), Sex (Male and Female), and Test Type (Cue Normal and Cue Switched). This analysis found a no significant main effects or interactions (all p > 0.19). We then examined whether the overall pattern using this measure supported a conclusion that goal-directed action was being expressed using a single-sample t-test. As there were no differences between groups, we compared the preference ratio across the entire sample to 0 (the score that would indicated that there was no preference). We found that preference score for the sample was significantly different from 0: t(102) = 2.7, p < 0.01. These results indicate that there was a significant devaluation effect (based on the lever-location) in Experiment 2 when the scores were normalized for the overall level of responding and that there was no evidence that the magnitude of this devaluation effect using this measure differed across the different groups.

4. Discussion

Our results provided no evidence for impairment of goal-directed behavior in a devaluation task after adolescent amphetamine or ketamine injections. This was true regardless of whether we used a test in which cue-light and lever-location information were congruent between training and test (allowing for compensation between strategies supported by different frontal cortex areas) or incongruent between training and test (preventing compensation between strategies). Below, we discuss several possible reasons for this lack of these effects of drug exposure and discuss the information our results can and cannot provide about the strategies used to guide devaluation in our task.

4.1 Evidence for Primary Use of a Lever-Location Strategy to Guide Behavior in Our Task with Conflicting Information

Our results were not informative about the possibility of compensation between strategies after drug exposure. We designed and conducted the experiments specifically to examine the possibility of impaired devaluation in the Cue Switched condition and not in the Cue Normal condition, which would indicate compensation between strategies used to guide goal-directed behavior. The failure to find impaired devaluation in the Cue Switched condition in the drug-exposed groups means our results are uninformative about whether compensation after drug exposure can help to maintain goal-directed behavior. However, our results largely replicate our previous findings about the relative role of the two types of strategies that can guide behavior. In both experiments, we replicated our previous pattern in which rats tested under the Cue Switched conditions primarily guide their responding according to the fixed location of the lever rather than based on the cue-light’s location [40]. Visual inspection of the devaluation effect in Experiment 2 using the leverpress/trial measure (Fig. 3B,C) suggested that the devaluation effect may have been smaller in the Cue Switched condition, but this was not supported by a Lever X Test Type interaction in the analysis of either the leverpress/trial measure or the preference ratio measure in Experiment 2. This visual pattern was not observed in Experiment 1. Additional research is necessary to assess whether different training conditions could lead to goal-directed behavior that is guided by cue-lights in neurobiologically intact rats.

4.2 Relation of Our Null Effect to Prior Literature on Long-Term Behavioral Effects of Psychostimulant Exposure on lOFC- and PL-Dependent Tasks

Our finding that amphetamine exposure did not impair goal-directed behavior contrasts with several prior demonstrations that psychostimulant exposure can lead to altered PL and/or lOFC function and goal-directed behavior impairments in devaluation tasks dependent on PL or lOFC function. Prior research has shown that psychostimulant exposure (through forced exposure or self-administration) alters the activity of PL and/or lOFC. For example, repeated amphetamine/cocaine injections or methamphetamine self-administration increases excitability and/or firing rate in PL days or weeks later [68, 69, 70, 71, 72]. Previous cocaine exposure also disrupts selective lOFC firing to cues that predict specific outcomes in a discrimination task [73]. There is also evidence for impairments in goal-directed behavior weeks after the final cocaine exposure in a devaluation task requiring a cue-based strategy [56], although the impairment could be explained by training and testing in a drug-paired environment rather than neurotoxic dysfunction [58, 59]. Likewise, prior research has demonstrated behavioral impairments weeks after the final cocaine, amphetamine, or methamphetamine exposure in a devaluation task requiring a lever-location strategy [51, 52, 53, 54, 55], although the impairment may be caused by faster habit learning rather than a failure of the neurobiological substrates of goal-directed behavior [57].

Our results may be congruent with the prior literature showing goal-directed behavior impairments in the devaluation task after prior psychostimulant exposure if these prior impairments were due to accelerated habit-formation (in tasks prone to formation of habits after extended training) or training/testing in drug-paired contexts rather than a stable neurotoxicity-induced dysfunction of the brain areas needed for goal-directed behavior. As noted above, prior research has demonstrated impairments in goal-directed behavior weeks after the final cocaine exposure in devaluation tasks requiring a cue-based strategy [56], but this experiment paired the behavioral training and testing environment with cocaine. Previous research has also shown that behavioral contexts associated with the psychostimulant methamphetamine lead to devaluation impairments that are not observed in the same rats when tested in a different context [58], so the cocaine-induced impairment in the cue-based task may be due to an interference effect from the cocaine-paired training and testing context. Many of the other demonstrations of impaired goal-directed behavior in devaluation tasks where behavior was guided by lever-location after cocaine or amphetamine exposure have used task versions with training with one lever-reinforcer relationship [51, 52, 54, 55] or a second response-reinforcer relationship was trained only after the cessation of training for the other response-reinforcer relationship [53]. Extended training can lead to habit-based devaluation insensitivity with variable interval schedules and/or extended training if only one response-reinforcer relationship is trained or if response-reinforcer relationships are trained in different contexts [1, 27], but goal-directed behavior in operant responding in rodents occurs if multiple response-reinforcer relationships are trained in the same context [74].

Our results mirror a pattern observed in multiple-response/multiple-reinforcer operant devaluation (conditions that don’t tend to lead to habit-formation) after exposure to other drugs of abuse. Prior exposure to subchronic cocaine or methamphetamine [57, 58, 75] or a neurotoxic single-day regimen of methamphetamine [76] do not cause a generalized goal-directed behavior impairment in devaluation tasks where two different response options lead to separate rewards, possibly because these procedures are resistant to the formation of habits [74]. In these cases, cues associated with a drug can specifically interfere with goal-directed behavior in the presence of those cues [58, 75], but no impairment is seen when these cues are absent.

However, there are several methodological considerations. First, the timing of the amphetamine exposure may have affected our results. While previous research suggests that there may be more significant long-term behavioral and neurobiological effects of drug exposure if this exposure occurs during adolescence rather than adulthood (as reviewed in [50]), it is possible that amphetamine exposure during adolescence had less of a long-term effect on behavior than if it were given during adulthood. Relatedly, it is possible that we could have found an impairment in devaluation if we had trained and tested the rats with a shorter interval between amphetamine exposure and training/testing. Second, it is possible that higher doses of amphetamine could lead to impaired devaluation. We based our injection regimen and time of exposure on a previous study that showed that 3 mg/kg injections of amphetamine every-other day from PND 27–45 led to decreased bursting in PL in response to saline injections during adulthood [60]. Our 3 mg/kg dose was also higher than the 2 mg/kg dose that was previously shown to impair devaluation in a task that predisposes rats towards habit learning if rats are trained for enough sessions (in a previous experiment with 7 once daily injections for 7 days during adulthood) [54]. However, we did not assess the effects of amphetamine exposure at a range of doses and it is possible that higher doses would lead to devaluation impairments in tasks that do not predispose rats to habit learning if they are extensively trained. Third, while our predicted impairments in goal-directed behavior did not depend upon the presence of sensitization to the effects of psychostimulants, several of the previous reports of psychostimulant exposure impairing devaluation also showed that the impaired rats exhibited locomotor sensitization to the effect of the psychostimulant [54, 56]. As we did not assess locomotor sensitization, it is unclear whether our amphetamine exposure regimen led to sensitization. However, the level of sensitization did not correlate with the level of devaluation impairment in the previous experiments that assessed it [54, 56], so it is also unclear whether psychomotor sensitization is required for devaluation impairments. Finally, it is possible that the timing of our injections (specifically- during the dark phase of the light-dark cycle) may have affected our results, as there is prior evidence for the light-dark cycle affecting the sensitivity to, pharmacokinetics of, and/or intake of a variety of drugs of abuse (for example, see [77, 78, 79, 80]). We gave injections during the dark phase to rats on a reverse light-dark cycle, while most of the previous experiment examining long-term effects of psychostimulants on devaluation and that reported their lighting conditions reported maintaining rats on a regular light cycle (with injections presumably occurring during the day) or specified injecting during the light phase [53, 54, 56, 58, 81] (but see [55]).

While we found relatively clear evidence that the particular amphetamine exposure regimen and washout period did not lead to devaluation impairment in our task, additional research is needed. Specifically, future research should (1) determine if our amphetamine exposure regimen would lead to accelerated habit formation in tasks that predispose rats towards habit learning if rats are extensively trained, (2) determine if this exposure regimen would impair behavior in the devaluation if given during adulthood, (3) determine if other exposure regimens such as higher doses or shorter washout periods might lead to a goal-directed behavior impairment, (4) determine if our amphetamine exposure led to an impairment in lOFC function that was obscured by intact PL function or whether it did not impair PL or lOFC function, and (5) determine if this exposure regimen leads to locomotor sensitization.

4.3 Relation of Our Null Effect to Prior Literature on Long-Term Behavioral Effects of Dissociative Anesthetic Exposure on lOFC- and PL-Dependent Tasks

Our finding that ketamine exposure did not impair goal-directed behavior contrasts with several prior demonstrations that dissociative anesthetic exposure can lead to altered PL and/or lOFC function and impairments in tasks dependent on PL or lOFC function, although the prior literature on devaluation tasks is relatively sparse. One previous experiment found that acute injections of the non-competitive N-methyl-D-aspartate (NMDA) receptor (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) between the satiation period and the leverpress devaluation test impaired the selective decrease in leverpressing for the reward in a devaluation task in which only one response-reward relationship had been trained (with decreased leverpressing regardless of whether the operant reinforcer or another food was sated) [82]. However, this experiment examined acute effects with pretest injections rather than long-term effects in a drug-free state. In addition, the NMDA receptor antagonist used (MK-801 vs. ketamine) and the type of devaluation task (single lever-reward free operant task vs. two response-cue-reward relationships) differed from the parameters used in our study. Therefore, it is unclear which factor or factors distinguish our results from this previous one. Conversely, our lab previously examined long-term effects of a ketamine regimen with higher doses and fewer injections (3 once-daily injections of a higher sub-anesthetic 50 mg/kg or anesthetic 100 mg/kg dose) and found no effects of ketamine exposure on goal-directed behavior in the same task used here with a Cue Normal test [83]. However, there was no Cue Switched test given, so it is unclear whether this represents intact function of PL, lOFC, or both, as goal-directed behavior in the Cue Normal task is intact if only PL or only lOFC is lesioned [44], and the fewer number of exposures may have led to a less pronounced effect than long-term exposure. Therefore, there is little to no data on what would be expected for long-term effects of our ketamine exposure regimen in the current experiment.

It is unclear whether our ketamine exposure regimen failed to alter prefrontal cortex (PFC) function or whether any impairments may have occurred but did not last until our training/testing period. Prior literature suggests that there are impairments in the reversal learning task (which is dependent on lOFC [62, 63, 64]) after subchronic exposure to ketamine or the NMDA receptor antagonist drug phencyclidine (PCP) under some conditions [61, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93] and no impairment under other conditions [65, 94, 95, 96, 97, 98, 99, 100]. Likewise, prior literature suggests that there are impairments in extradimensional shifting in the attentional set-shifting or strategy set-shifting tasks (which is dependent on PL [66, 101, 102]) after subchronic exposure to PCP or ketamine [61, 65, 85, 91, 95, 97, 98, 99, 100]. There were relatively uniform regimens of exposure and washout in these previous studies, with the vast majority of experiments giving dissociative anesthetics during adulthood and having testing between 3 and 14 days later (compared with the much wider range in age of exposure and washout periods ranging from 24 h to 6 weeks for psychostimulant exposure and testing). While this simplifies the prior literature, it may limit the generalizability of these findings to make predictions about our experiment.

There are several methodological considerations for the interpretation of our findings. First, our devaluation effect was smaller in Experiment 2 than in Experiment 1. Although all 8 groups (across each Male vs. Female X Ketamine vs. Saline X Cue Normal vs. Cue Switched condition) exhibited numerically lower responding to the devalued lever than to the nondevalued lever, it is possible that this weaker overall devaluation effect may have made it more difficult to detect any potential decrease in the magnitude of the devaluation effect after ketamine. This was particularly evident in visual inspection of Saline group rats given Cue Switched conditions, although there was no significant Test Type X Lever interaction. Second, it is possible that higher doses of ketamine could lead to impaired devaluation. We based our injection regimen on dosing regimens previously shown to lead to behavioral impairments consistent with dysfunction of PL and/or lOFC [61, 65]. However, we did not assess the effects of ketamine exposure at a range of doses or lengths of exposure, and it is possible that higher doses or more extensive exposure are required to lead to devaluation impairments. Third, the timing of the ketamine exposure may have affected our results. As the experiments reviewed in the previous paragraph were performed on rodents during or near adulthood and they all began behavioral testing within ~2 weeks or less after the final PCP or ketamine injection, it is unclear how relevant they are for predicting PL and lOFC function more than 5 weeks after ketamine exposure in adolescent rats. While previous research suggests that there may be more significant long-term behavioral and neurobiological effects of drug exposure if this exposure occurs during adolescence, rather than adulthood (as reviewed in [50]), it is possible that ketamine exposure during adolescence had less of a long-term effect on behavior than if it were given during adulthood. In addition, previous research has found that an identical once-daily PCP exposure led to opposite effects on activity regulated cytoskeletal-associated protein (Arc) mRNA in PL and lOFC 3 days after the final injection in rats of different ages, with decreased mRNA in adolescent rats and increased mRNA if given during early adulthood [103]. Alternatively, it is possible that adolescent ketamine exposure did lead to altered function of PL and/or lOFC for several weeks after exposure, but the more extended washout period (more than 5 weeks from the final injection until cued-trial training began) in the current experiment led to a recovery over time.

While we found no evidence that the particular ketamine exposure regimen and washout period led to devaluation impairment in our task, additional research is needed. Specifically, future research should (1) determine if our ketamine exposure regimen would lead to accelerated habit formation in tasks that predispose rats towards habit learning if rats are extensively trained, (2) determine if this exposure regimen would impair behavior in the devaluation if given during adulthood, (3) determine if other exposure regimens such as higher doses or shorter washout periods might lead to a goal-directed behavior impairment, and (4) determine if our ketamine exposure regimen led to an impairment in lOFC function that was obscured by intact PL function or whether it did not impair PL or lOFC function.

5. Conclusions

In conclusion, our results provided no evidence for impairment of goal-directed behavior after adolescent amphetamine or ketamine injections, regardless of whether we used a devaluation test that allowed for compensation between strategies or a test that prevented compensation between strategies. It is unclear whether this represents (1) a lack of effect of prior drug exposure (at this particular dosing regimen, age of exposure, and washout period) on the neural substrates of goal-directed behavior in tasks that do not predispose animals towards habitual behavior and do not present drug-related contextual cues during training/testing, (2) neurobiological dysfunction that faded over our longer washout period, or (3) impaired lOFC function obscured by intact goal-directed behavior based on the lever-location. Additional research is needed to differentiate between these possibilities.

Availability of Data and Materials

Data will be provided upon request to any qualified person who requests it.

Author Contributions

HF, CM, and CLP acquired funding for the project. IRD, HF, and CLP designed the research study. IRD, HF, CM, JM, and CLP performed the research. CLP analyzed the data. IRD and CLP wrote the first draft of the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

All procedures and animal care were in accordance with the Kansas State University Institutional Animal Care and Use Committee guidelines (approvals #4345 and 4422), the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals, and United States federal law.

Acknowledgment

The authors acknowledge the undergraduate members of the Pickens lab for useful lab meeting discussions on the issues described in this manuscript.

Funding

This work was partially supported by the National Institutes of Health [grant number P20 GM113109-01A1], a Sigma Xi Grant in Aid of Research (C.M.), a Histochemical Society Capstone Grant (C.M.) and a Histochemical Society Cornerstone Grant (H.F.) and internal Kansas State University funds.

Conflict of Interest

The authors declare no conflict of interest. Charles L. Pickens is serving as one of the Editorial Board members of this journal. We declare that Charles L. Pickens had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Gernot Riedel.

References
[1]
Adams CD. Variations in the sensitivity of instrumental responding to reinforcer devaluation. Quarterly Journal of Experimental Psychology. 1982; 34: 77–98.
[2]
Hollland PC, Rescorla RA. The effect of two ways of devaluing the unconditioned stimulus after first- and second-order appetitive conditioning. Journal of Experimental Psychology. Animal Behavior Processes. 1975; 1: 355–363.
[3]
Alvares GA, Balleine BW, Guastella AJ. Impairments in goal-directed actions predict treatment response to cognitive-behavioral therapy in social anxiety disorder. PloS One. 2014; 9: e94778.
[4]
Alvares GA, Balleine BW, Whittle L, Guastella AJ. Reduced goal-directed action control in autism spectrum disorder. Autism Research: Official Journal of the International Society for Autism Research. 2016; 9: 1285–1293.
[5]
Gillan CM, Papmeyer M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, et al. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. The American Journal of Psychiatry. 2011; 168: 718–726.
[6]
Morris RW, Quail S, Griffiths KR, Green MJ, Balleine BW. Corticostriatal control of goal-directed action is impaired in schizophrenia. Biological Psychiatry. 2015; 77: 187–195.
[7]
Morris RW, Cyrzon C, Green MJ, Le Pelley ME, Balleine BW. Impairments in action-outcome learning in schizophrenia. Translational Psychiatry. 2018; 8: 54.
[8]
Geurts HM, de Wit S. Goal-directed action control in children with autism spectrum disorders. Autism: the International Journal of Research and Practice. 2014; 18: 409–418.
[9]
Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LHE, Luijten M, et al. Carrots and sticks fail to change behavior in cocaine addiction. Science (New York, N.Y.). 2016; 352: 1468–1471.
[10]
Hogarth L, Lam-Cassettari C, Pacitti H, Currah T, Mahlberg J, Hartley L, et al. Intact goal-directed control in treatment-seeking drug users indexed by outcome-devaluation and Pavlovian to instrumental transfer: critique of habit theory. The European Journal of Neuroscience. 2019; 50: 2513–2525.
[11]
Luijten M, Gillan CM, de Wit S, Franken IHA, Robbins TW, Ersche KD. Goal-Directed and Habitual Control in Smokers. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. 2020; 22: 188–195.
[12]
Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman ATF, Penninx BWJH, et al. Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Translational Psychiatry. 2013; 3: e337.
[13]
van Timmeren T, Quail SL, Balleine BW, Geurts DEM, Goudriaan AE, van Holst RJ. Intact corticostriatal control of goal-directed action in Alcohol Use Disorder: a Pavlovian-to-instrumental transfer and outcome-devaluation study. Scientific Reports. 2020; 10: 4949.
[14]
Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET. Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain: a Journal of Neurology. 2011; 134: 2013–2024.
[15]
Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biological Psychiatry. 2002; 51: 134–142.
[16]
London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry. 2004; 61: 73–84.
[17]
McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 1998; 18: 8417–8422.
[18]
Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. The American Journal of Psychiatry. 2001; 158: 1206–1214.
[19]
Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. The American Journal of Psychiatry. 2003; 160: 1699–1701.
[20]
Bahnemann M, Hamel J, De Beukelaer S, Ohl S, Kehrer S, Audebert H, et al. Compensatory eye and head movements of patients with homonymous hemianopia in the naturalistic setting of a driving simulation. Journal of Neurology. 2015; 262: 316–325.
[21]
Hagoort P, Wassenaar M, Brown C. Real-time semantic compensation in patients with agrammatic comprehension: electrophysiological evidence for multiple-route plasticity. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100: 4340–4345.
[22]
Ham TE, Bonnelle V, Hellyer P, Jilka S, Robertson IH, Leech R, et al. The neural basis of impaired self-awareness after traumatic brain injury. Brain: a Journal of Neurology. 2014; 137: 586–597.
[23]
Jones TA. Motor compensation and its effects on neural reorganization after stroke. Nature Reviews. Neuroscience. 2017; 18: 267–280.
[24]
Olsen A, Brunner JF, Indredavik Evensen KA, Finnanger TG, Vik A, Skandsen T, et al. Altered Cognitive Control Activations after Moderate-to-Severe Traumatic Brain Injury and Their Relationship to Injury Severity and Everyday-Life Function. Cerebral Cortex (New York, N.Y.: 1991). 2015; 25: 2170–2180.
[25]
Balleine BW, Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology. 1998; 37: 407–419.
[26]
Corbit LH, Balleine BW. The role of prelimbic cortex in instrumental conditioning. Behavioural Brain Research. 2003; 146: 145–157.
[27]
Killcross S, Coutureau E. Coordination of actions and habits in the medial prefrontal cortex of rats. Cerebral Cortex (New York, N.Y.: 1991). 2003; 13: 400–408.
[28]
Ostlund SB, Balleine BW. Lesions of medial prefrontal cortex disrupt the acquisition but not the expression of goal-directed learning. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2005; 25: 7763–7770.
[29]
Tran-Tu-Yen DAS, Marchand AR, Pape JR, Di Scala G, Coutureau E. Transient role of the rat prelimbic cortex in goal-directed behaviour. The European Journal of Neuroscience. 2009; 30: 464–471.
[30]
Baxter MG, Parker A, Lindner CC, Izquierdo AD, Murray EA. Control of response selection by reinforcer value requires interaction of amygdala and orbital prefrontal cortex. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2000; 20: 4311–4319.
[31]
Gallagher M, McMahan RW, Schoenbaum G. Orbitofrontal cortex and representation of incentive value in associative learning. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 1999; 19: 6610–6614.
[32]
Izquierdo A, Suda RK, Murray EA. Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2004; 24: 7540–7548.
[33]
Lichtenberg NT, Pennington ZT, Holley SM, Greenfield VY, Cepeda C, Levine MS, et al. Basolateral Amygdala to Orbitofrontal Cortex Projections Enable Cue-Triggered Reward Expectations. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2017; 37: 8374–8384.
[34]
Panayi MC, Killcross S. Functional heterogeneity within the rodent lateral orbitofrontal cortex dissociates outcome devaluation and reversal learning deficits. eLife. 2018; 7: e37357.
[35]
Pickens CL, Saddoris MP, Setlow B, Gallagher M, Holland PC, Schoenbaum G. Different roles for orbitofrontal cortex and basolateral amygdala in a reinforcer devaluation task. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2003; 23: 11078–11084.
[36]
Pickens CL, Saddoris MP, Gallagher M, Holland PC. Orbitofrontal lesions impair use of cue-outcome associations in a devaluation task. Behavioral Neuroscience. 2005; 119: 317–322.
[37]
Rhodes SEV, Murray EA. Differential effects of amygdala, orbital prefrontal cortex, and prelimbic cortex lesions on goal-directed behavior in rhesus macaques. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2013; 33: 3380–3389.
[38]
West EA, DesJardin JT, Gale K, Malkova L. Transient inactivation of orbitofrontal cortex blocks reinforcer devaluation in macaques. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2011; 31: 15128–15135.
[39]
West EA, Forcelli PA, McCue DL, Malkova L. Differential effects of serotonin-specific and excitotoxic lesions of OFC on conditioned reinforcer devaluation and extinction in rats. Behavioural Brain Research. 2013; 246: 10–14.
[40]
Fisher H, Pajser A, Pickens CL. Pre-training inactivation of basolateral amygdala and mediodorsal thalamus, but not orbitofrontal cortex or prelimbic cortex, impairs devaluation in a multiple-response/multiple-reinforcer cued operant task. Behavioural Brain Research. 2020; 378: 112159.
[41]
Fiuzat EC, Rhodes SEV, Murray EA. The Role of Orbitofrontal-Amygdala Interactions in Updating Action-Outcome Valuations in Macaques. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2017; 37: 2463–2470.
[42]
Rudebeck PH, Murray EA. Dissociable effects of subtotal lesions within the macaque orbital prefrontal cortex on reward-guided behavior. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2011; 31: 10569–10578.
[43]
Zeeb FD, Winstanley CA. Functional disconnection of the orbitofrontal cortex and basolateral amygdala impairs acquisition of a rat gambling task and disrupts animals’ ability to alter decision-making behavior after reinforcer devaluation. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2013; 33: 6434–6443.
[44]
Fisher H, Lin H, May J, McLean C, Pickens CL. Prefrontal cortex neural compensation during an operant devaluation task. bioRxiv. 2021. (preprint)
[45]
Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry. 2002; 59: 1039–1044.
[46]
Miech RA, Johnston LD, Patrick ME, O’Malley PM, Bachman JH, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2022: Secondary school students. In Monitoring the Future Monograph Series. Institute for Social Research, University of Michigan, Ann Arbor, MI. 2022. Available at: https://monitoringthefuture.org/wp-content/uploads/2022/12/mtf2022.pdf (Accessed: 29 February 2024).
[47]
Strashny A. Age of Substance Use Initiation Among Treatment Admissions Aged 18 to 30. The CBHSQ Report. 2014; 1–9.
[48]
Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug and Alcohol Dependence. 1995; 40: 9–15.
[49]
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. 2013. Available at: https://www.samhsa.gov/data/sites/default/files/NSDUHresults2012/NSDUHresults2012.pdf (Accessed 29 February 2024).
[50]
Spear LP. Consequences of adolescent use of alcohol and other drugs: Studies using rodent models. Neuroscience and Biobehavioral Reviews. 2016; 70: 228–243.
[51]
Corbit LH, Chieng BC, Balleine BW. Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2014; 39: 1893–1901.
[52]
Furlong TM, Corbit LH, Brown RA, Balleine BW. Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum. Addiction Biology. 2018; 23: 857–867.
[53]
LeBlanc KH, Maidment NT, Ostlund SB. Repeated cocaine exposure facilitates the expression of incentive motivation and induces habitual control in rats. PloS One. 2013; 8: e61355.
[54]
Nelson A, Killcross S. Amphetamine exposure enhances habit formation. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2006; 26: 3805–3812.
[55]
Nordquist RE, Voorn P, de Mooij-van Malsen JG, Joosten RNJMA, Pennartz CMA, Vanderschuren LJMJ. Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatment. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology. 2007; 17: 532–540.
[56]
Schoenbaum G, Setlow B. Cocaine makes actions insensitive to outcomes but not extinction: implications for altered orbitofrontal-amygdalar function. Cerebral Cortex (New York, N.Y.: 1991). 2005; 15: 1162–1169.
[57]
Halbout B, Liu AT, Ostlund SB. A Closer Look at the Effects of Repeated Cocaine Exposure on Adaptive Decision-Making under Conditions That Promote Goal-Directed Control. Frontiers in Psychiatry. 2016; 7: 44.
[58]
Furlong TM, Supit ASA, Corbit LH, Killcross S, Balleine BW. Pulling habits out of rats: adenosine 2A receptor antagonism in dorsomedial striatum rescues meth-amphetamine-induced deficits in goal-directed action. Addiction Biology. 2017; 22: 172–183.
[59]
Ostlund SB, Maidment NT, Balleine BW. Alcohol-Paired Contextual Cues Produce an Immediate and Selective Loss of Goal-directed Action in Rats. Frontiers in Integrative Neuroscience. 2010; 4: 19.
[60]
Sherrill LK, Gulley JM. Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood. Brain Research. 2018; 1694: 111–120.
[61]
Floresco SB, Zhang Y, Enomoto T. Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behavioural Brain Research. 2009; 204: 396–409.
[62]
Ghods-Sharifi S, Haluk DM, Floresco SB. Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning. Neurobiology of Learning and Memory. 2008; 89: 567–573.
[63]
McAlonan K, Brown VJ. Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behavioural Brain Research. 2003; 146: 97–103.
[64]
Schoenbaum G, Setlow B, Nugent SL, Saddoris MP, Gallagher M. Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport. 2002; 13: 885–890.
[65]
Nikiforuk A, Popik P. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology. 2012; 220: 65–74.
[66]
Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2000; 20: 4320–4324.
[67]
Pickens CL, Hougham A, Kim J, Wang C, Leder J, Line C, et al. Impairments in expression of devaluation in a Pavlovian goal-tracking task, but not a free operant devaluation task, after fentanyl exposure in female rats. Behavioural Brain Research. 2024; 458: 114761.
[68]
Aguilar-Rivera MI, Casanova JP, Gatica RI, Quirk GJ, Fuentealba JA. Amphetamine sensitization is accompanied by an increase in prelimbic cortex activity. Neuroscience. 2015; 288: 1–9.
[69]
Hearing M, Kotecki L, Marron Fernandez de Velasco E, Fajardo-Serrano A, Chung HJ, Luján R, et al. Repeated cocaine weakens GABA(B)-Girk signaling in layer 5/6 pyramidal neurons in the prelimbic cortex. Neuron. 2013; 80: 159–170.
[70]
Nasif FJ, Hu XT, White FJ. Repeated cocaine administration increases voltage-sensitive calcium currents in response to membrane depolarization in medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 2005; 25: 3674–3679.
[71]
Nasif FJ, Sidiropoulou K, Hu XT, White FJ. Repeated cocaine administration increases membrane excitability of pyramidal neurons in the rat medial prefrontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 2005; 312: 1305–1313.
[72]
Parsegian A, Glen WB, Jr, Lavin A, See RE. Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biological Psychiatry. 2011; 69: 253–259.
[73]
Stalnaker TA, Roesch MR, Franz TM, Burke KA, Schoenbaum G. Abnormal associative encoding in orbitofrontal neurons in cocaine-experienced rats during decision-making. The European Journal of Neuroscience. 2006; 24: 2643–2653.
[74]
Colwill RM, Rescorla RA. Instrumental responding remains sensitive to reinforcer devaluation after extensive training. Journal of Experimental Psychology: Animal Behavior Processes. 1985; 11: 520–536.
[75]
Schmitzer-Torbert N, Apostolidis S, Amoa R, O’Rear C, Kaster M, Stowers J, et al. Post-training cocaine administration facilitates habit learning and requires the infralimbic cortex and dorsolateral striatum. Neurobiology of Learning and Memory. 2015; 118: 105–112.
[76]
Son JH, Latimer C, Keefe KA. Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2011; 36: 2441–2451.
[77]
Perreau-Lenz S, Zghoul T, de Fonseca FR, Spanagel R, Bilbao A. Circadian regulation of central ethanol sensitivity by the mPer2 gene. Addiction Biology. 2009; 14: 253–259.
[78]
Baird TJ, Gauvin D. Characterization of cocaine self-administration and pharmacokinetics as a function of time of day in the rat. Pharmacology, Biochemistry, and Behavior. 2000; 65: 289–299.
[79]
Pietila K, Laakso I, Ahtee L. Chronic oral nicotine administration affects the circadian rhythm of dopamine and 5-hydroxytryptamine metabolism in the striata of mice. Naunyn-Schmiedeberg’s Archives of Pharmacology. 1995; 353: 110–115.
[80]
Nordberg A, Bergh C. Effect of nicotine on passive avoidance behaviour and motoric activity in mice. Acta Pharmacologica et Toxicologica. 1985; 56: 337–341.
[81]
Nelson AJD, Killcross S. Accelerated habit formation following amphetamine exposure is reversed by D1, but enhanced by D2, receptor antagonists. Frontiers in Neuroscience. 2013; 7: 76.
[82]
Ozawa T, Itokazu T, Ichitani Y, Yamada K. Pharmacologically induced N-methyl-D-aspartate receptor hypofunction impairs goal-directed food seeking in rats. Neuropsychopharmacology Reports. 2021; 41: 526–531.
[83]
Pickens CL, Aurand L, Hunt J, Fisher H. Subchronic anesthetic ketamine injections in rats impair choice reversal learning, but have no effect on reinforcer devaluation. Behavioural Pharmacology. 2017; 28: 294–302.
[84]
Abdul-Monim Z, Neill JC, Reynolds GP. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Journal of Psychopharmacology (Oxford, England). 2007; 21: 198–205.
[85]
Dawson N, Thompson RJ, McVie A, Thomson DM, Morris BJ, Pratt JA. Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity. Schizophrenia Bulletin. 2012; 38: 457–474.
[86]
Idris N, Neill J, Grayson B, Bang-Andersen B, Witten LM, Brennum LT, et al. Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology. 2010; 208: 23–36.
[87]
McLean SL, Idris NF, Woolley ML, Neill JC. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology. 2009; 19: 440–450.
[88]
McLean SL, Woolley ML, Thomas D, Neill JC. Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology. 2009; 206: 403–414.
[89]
McLean SL, Neill JC, Idris NF, Marston HM, Wong EHF, Shahid M. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat. Behavioural Brain Research. 2010; 214: 240–247.
[90]
McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton DJ, Mackie C, et al. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology. 2011; 21: 333–343.
[91]
McLean SL, Idris NF, Grayson B, Gendle DF, Mackie C, Lesage AS, et al. PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. Journal of Psychopharmacology (Oxford, England). 2012; 26: 1265–1270.
[92]
Neill JC, Grayson B, Kiss B, Gyertyán I, Ferguson P, Adham N. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology. 2016; 26: 3–14.
[93]
Rajagopal L, Massey BW, Michael E, Meltzer HY. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice. Psychopharmacology. 2016; 233: 649–660.
[94]
Brigman JL, Ihne J, Saksida LM, Bussey TJ, Holmes A. Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice. Frontiers in Behavioral Neuroscience. 2009; 3: 2.
[95]
Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology. 2008; 198: 37–49.
[96]
McAllister KAL, Mar AC, Theobald DE, Saksida LM, Bussey TJ. Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia. Psychopharmacology. 2015; 232: 3883–3897.
[97]
McLean SL, Beck JP, Woolley ML, Neill JC. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats. Behavioural Brain Research. 2008; 189: 152–158.
[98]
Pedersen CS, Goetghebeur P, Dias R. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. Journal of Neuroscience Methods. 2009; 185: 66–69.
[99]
Rodefer JS, Murphy ER, Baxter MG. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. The European Journal of Neuroscience. 2005; 21: 1070–1076.
[100]
Rodefer JS, Nguyen TN, Karlsson JJ, Arnt J. Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2008; 33: 2657–2666.
[101]
Floresco SB, Block AE, Tse MTL. Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure. Behavioural Brain Research. 2008; 190: 85–96.
[102]
Ragozzino ME, Detrick S, Kesner RP. Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience. 1999; 19: 4585–4594.
[103]
Thomsen MS, Hansen HH, Mikkelsen JD. Opposite effect of phencyclidine on activity-regulated cytoskeleton-associated protein (Arc) in juvenile and adult limbic rat brain regions. Neurochemistry International. 2010; 56: 270–275.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top